Opening of monoterpene epoxide to a potent anti-Parkinson compound of para-menthane structure over heterogeneous catalysts

Martina Stekrova, Narendra Kumar, Päivi Mäki-Arvela, Atte Aho, Johan Linden, Konstantin P. Volcho, Nariman F. Salakhutdinov, Dmitry Yu Murzin*

*Korresponderande författare för detta arbete

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

16 Citeringar (Scopus)

Sammanfattning

High selectivity (82 %) to 3-methyl-6-(prop-1-en-2-yl)cyclohex-3-ene- 1,2-diol, a potent anti-Parkinson drug, was achieved in the isomerization of verbenol oxide at the conversion level of 96 % in N,N-dimethylacetamide at 140 °C over a metal modified zeolite, Fe-Beta-300 with SiO2 to Al2O3 ratio of 300. This catalyst exhibits both weak and medium strong Brønsted and Lewis acid sites.

OriginalspråkEngelska
Sidor (från-till)449-458
Antal sidor10
TidskriftReaction Kinetics, Mechanisms and Catalysis
Volym110
Nummer2
DOI
StatusPublicerad - aug. 2013
MoE-publikationstypA1 Tidskriftsartikel-refererad

Fingeravtryck

Fördjupa i forskningsämnen för ”Opening of monoterpene epoxide to a potent anti-Parkinson compound of para-menthane structure over heterogeneous catalysts”. Tillsammans bildar de ett unikt fingeravtryck.

Citera det här